Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

PRIMELUNG

K-Number: K024149 · 2003-02-21

Decision Date2003-02-21
Product CodeJAK
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

PRIMELUNG is the device name listed in this FDA 510(k) record. The listed applicant is Accuimage Diagnostics Corp.. It received FDA 510(k) clearance on 2003-02-21 under 510(k) number K024149. The device is classified under product code JAK. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the PRIMELUNG?

PRIMELUNG is a medical device that received FDA 510(k) clearance on 2003-02-21. The listed applicant is Accuimage Diagnostics Corp.. The 510(k) number is K024149.

When did PRIMELUNG receive FDA 510(k) clearance?

PRIMELUNG received FDA 510(k) clearance on 2003-02-21, under 510(k) number K024149.

Who is the listed applicant for PRIMELUNG?

The FDA 510(k) record lists Accuimage Diagnostics Corp. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for PRIMELUNG?

The FDA product code for PRIMELUNG is JAK.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing Accuimage Diagnostics Corp. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: JAK)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑